On the one hand, SAA has been implicated in triggering hepatic steatosis and intrahepatic inflammatory response by forming an SAA/TLR4/NF-κB/SAA feed-forward regulatory circuit 34. The gene discussed is NFKB1; the disease is fatty liver disease.